Cycle de Séminaires du Quartier de la Création Vivre ou vivre mieux? DHU 2020 Médecine personnalisée des maladies chroniques
|
|
- Rosemary Stephens
- 6 years ago
- Views:
Transcription
1 Cycle de Séminaires du Quartier de la Création 2014 Vivre ou vivre mieux? Education Human Sciences Arts Quartier HU DHU 2020 Médecine personnalisée des maladies chroniques Un exemple de structuration de la recherche pour la médecine 4P Antoine Magnan, Karine Botturi- Cavaillès
2 Care research interface: a 10 years old Nantese speciality Early 2000» Cohorts of patients Genetics Genomics» Pathophysiology: animal models «Modèle Nantais» inspiring the Marescaux commission on the future of University Hospitals in France: Instituts HU, Pôles HU, Départements HU RHU
3 Care research interface: a 10 years old Nantese speciality Early 2000 Education» Cohorts of patients Genetics Genomics» Pathophysiology: animal models «Modèle Nantais» inspiring the Marescaux commission on the future of University Hospitals in France: Instituts HU, Pôles HU, Départements HU RHU
4 10 years later cohorts, biobanks, models + Education
5 HEALTH CHALLENGES IN THE NEXT DECADES Increase of life length Increase of chronic diseases Increase of health costs Economic crisis
6 HEALTH CHALLENGES IN THE NEXT DECADES Increase of life length Plan the «well ageing» Predict / Prevent chronic diseases Focus on health no more on disease Contain Health costs
7 NEW DRUGS Biotherapies Too expensive to be given to everybody MUST be targeted
8 4P MEDICINE = THE OPPORTUNITY personalized & participative Strategies Predict diseases Predict response Prevent diseases Targeted treatments Possible in XXIth century? - Technology already exists - Will the society be mature enough to accept it?
9 10 years later cohorts, biobanks, models + Education
10 Education UMR CNRS 6297 Droit et Changement Social Equipe Normes, Maladies et Société Human Sciences
11 Translational research strategy of DHU2020 Prevention Prevention Therapeutic targets Education Biomarkers Biocollections Genetics Clinical trials Risk factors Patients Patients Models Cohorts "omics" Personalized medicine Phenotypes Endotypes
12 Prevention Prevention Therapeutic targets Biomarkers Biocollections Genetics Clinical trials Education Risk factors Patients Patients Human Sciences Models Cohorts "omics" Personalized medicine Phenotypes Endotypes Human Sciences
13 PS1 EPIDEMIOLOGY VACARME PS2 BIOCOLLECTIONS healthy people from the Pays de La Loire Region - New biocollections : - GAIA : intra-cranial aneurysm (n=280) - HYPOCHOL : hypobetalipoproteinemia - RAY GENE : Raynaud s phenomenon - Non atopic asthma
14 PS3 GENETICS PS4 PHYSIOPATHOLOGY Differenciation of UhiPS in hepatocytes Modelization of hypercholestérolemia from ipsc Cell Optic System New genes of intra-cranial aneurysm EDUCATION Associate professor of genetics 2015 CALLS: «Animal models» «EMERGENCE»
15 COLT- SysClad COLT : COhort in Lung Transplantation Multicentric Cohort Sep : 12 French and Belgian centers of lung transplantationde TP > Lung transplants, follow-up 5 years Chronic Lung Allograft Dysfunction Biocollection (> samples) Database A Magnan A Haloun C Dromer M Stern S Mussot O Brugière (Bichat), V Boussaud (HEGP) M Dahan JF Mornex C Knoop L Nicod JD Aubert C Pison R Kessler C Benden SysCLAD : Systems prediction of Chronic Lung Allograft Dysfunction CLAD modelization M Reynaud-Gaubert
16 Chronic Lung Allograft Dysfunction Pain M, PhD thesis 2014, in preparation Royer P, in preparation 6 mois 1 an Network N 2: Developmental Disorder, Immunological Disease, Hematological System Development and Function
17 Asthma: from disease to new drug dicovery asthma Biological screening & Hit/lead refinement Patients Resistance (cmh2o.s/ml) *** 1 5 Animal model (SM-Rac1-KO) In silico screening Pharmacophore design Cell & tissue models (human) Molecular mechanisms Target identification Sauzeau V, Loirand G, Magnan A (PCT/EP2014/062402)
18 Education Questioning the transformations of Health care system What does personalized medicine mean for health care providers and researchers? H. Lecompte DCS, DHU 2020 Human Sciences ASHAM project: Sociological analysis of life habits in adults with type 1 myotonyc dystrophy A.C. Hardy, DCS / Y. Pereon, l institut du thorax
19 Education & Dissemination Autumn School: personalized medicine, 9, 10th Education Human Sciences october, 105 participants DHU2020 workshops 4 research calls L intestin au cœur des métabolismes Remodelages ips et médecine personnalisée Allergies System biology MD, PhD cursus Site dhu2020.org Vivre ou vivre mieux
20 UMR CNRS 6297 Droit et Changement Social Equipe Normes, Maladies et Société Education Human Sciences SyMeTRIC : Systems Medicine: Toward a & Innovation Centre (Région Pays de La Loire, Atanpôle biothérapies) Ecosystèmes d Excellences: Plan d investissements d Avenir 2 Initiatives d excellence (IDEX): Université Bretagne Loire Recherche Hospitalo-Universitaire
21 Quartier de la Création Education Human Sciences Arts
22
23 Quartier de la Création Education Human Sciences Arts Quartier HU CHU de Nantes 2023
24
HCERES report on research unit:
Research units HCERES report on research unit: Centre de Recherche en Transplantation et Immunologie CRTI Under the supervision of the following institutions and research bodies: Université de Nantes Institut
More informationTopic: Genome-Environment Interactions in Inflammatory Skin Disease
Topic: Genome-Environment Interactions in Inflammatory Skin Disease All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be
More informationDepartment of Research evaluation. Nutrition-Genetics and Exposure to Environmental Risks NGERE
Department of Research evaluation report on research unit: Nutrition-Genetics and Exposure to Environmental Risks NGERE under the supervision of the following institutions and research bodies: Université
More informationGenomic Medicine in France
Genomic Medicine in France Catherine Nguyen, PhD Director ITMO GGB Genetic, Genomic & Bioinformatic Advancing Disease Modeling in Animal-Based research in Support of Precision Medecine: a Workshop ILAR
More informationBuilding molecular handprints: a systems biology approach to complex diseases
Building molecular handprints: a systems biology approach to complex diseases Bertrand De Meulder, PhD EISBM, CIRI UMR5308, CNRS-ENS-UCBL-INSERM, Lyon, France SIMONCO Workshop, 27th June 2016 Phenotypes
More informationBioXplain The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology
The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology BioXplain 2009 Pharma R&D critical challenge Despite increasing investments in Technology
More informationVision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University
Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through
More informationreport on research unit:
Department of Research Evaluation report on research unit: Individual Profiling and Prevention of Risks with Immunosuppressive Therapies and Transplantation IPPRITT under the supervision of the following
More informationTRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University
TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS H a n n s Lochmüller, Newcastle University Addressing the translational pathway 2 Trials Gene identification/ pathophysiology
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationComplex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine
Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative
More informationMRC Stratified Medicine Initiative
MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified
More informationAll research lines at the LMU have a strong methodological focus
Content: Genetic Epidemiology and Statistical Genetics in Complex Diseases... 2 Molecular Epidemiology of Complex Phenotypes... 2 Clinical Trials and Translational Medicine... 3 Clinical Epidemiology and
More informationSuccessful Academia-Pharma Collaboration Drug Discovery and Clinical Development
Successful Academia-Pharma Collaboration Drug Discovery and Clinical Development Toshio MIYATA Tohoku University Graduate School of Medicine United Centers for Advanced Research and Translational Medicine
More informationEthical and Welfare Considerations Regarding Precision Animal Modeling
Advancing Disease Modeling in Animal Based Research in Support of Precision Medicine ILAR Roundtable October 5, 2017 Ethical and Welfare Considerations Regarding Precision Animal Modeling Elizabeth Heitman,
More informationHCERES report on research unit:
Research units HCERES report on research unit: Thérapeutiques Cliniques et Expérimentales des Infections Under the supervision of the following institutions and research bodies: Université de Nantes Evaluation
More informationA bold vision for 2025
Leading the Biomedical Revolution in Precision Health: How Stanford Medicine is Developing the Next Generation of Health Annual Stanford Medicine Population Health Sciences Colloquium October 26, 2015
More informationFrom Gene-Targeted Tests to Genome-Wide Data in Cancer Genetics: A Paradigm for the Development of Personalised Genomic Medicine?
From Gene-Targeted Tests to Genome-Wide Data in Cancer Genetics: A Paradigm for the Development of Personalised Genomic Medicine? Third workshop Genomic Data: Challenges to the Concept and Practice of
More informationPATIENT STRATIFICATION. 15 year A N N I V E R S A R Y. The Life Sciences Knowledge Management Company
PATIENT STRATIFICATION Treat the Individual with the Knowledge of All BIOMAX 15 year A N N I V E R S A R Y The Life Sciences Knowledge Management Company Patient Stratification Tailoring treatment of the
More informationThe promise of cell therapy for liver diseases: hurdles and success in drug development Beatrice De Vos, MD, PhD, BCPM (CMO PB)
The promise of cell therapy for liver diseases: hurdles and success in drug development Beatrice De Vos, MD, PhD, BCPM (CMO PB) Research Symposium on digestive and liver diseases European Parliament, Brussels
More informationPersonalised Medicine Regulatory Issues
Personalised Medicine Regulatory Issues INFRAFRONTIER / IMPC Stakeholder Meeting Presented by Marisa Papaluca on 14 November 2017 Senior Scientific Advisor, Scientific Committees Regulatory Science Strategy
More informationData Mining for Genomic- Phenomic Correlations
Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center
More informationBioXplain The Alliance for Integrative Biology
The Alliance for Integrative Biology The First Open Platform for Iterative, Predictive and Integrative Biology Manuel GEA Co-founder & CEO Bio-Modeling Systems BioXplain 2009 Pharma R&D critical challenge
More informationThe Wonderful World of Informatics
The Wonderful World of Informatics VI Jornadas Universitarias de Sistemas de Informción en Salud 31 de octubre, 1 y 2 de noviembre 2011 W. Ed Hammond, PhD, FACMI, FAIMI, FAIMBE, FHL7 Director, Duke Center
More informationHector R. Wong, MD Division of Critical Care Medicine Cincinnati Children s Hospital Medical Center Cincinnati Children s Research Foundation
Mechanisms of Sepsis Exploiting Pathogenic Genes Hector R. Wong, MD Division of Critical Care Medicine Cincinnati Children s Hospital Medical Center Cincinnati Children s Research Foundation Critical Care
More informationInnovative Medicines Initiative - the story so far
Innovative Medicines Initiative - the story so far Ruxandra Draghia-Akli MD PhD Director Health, Research & DG Health Research at a Crossroads Are Public-Private Partnerships the Way Forward? European
More informationCBME/INSERM-Lille, France Mini-symposium
CBME/INSERM-Lille, France Mini-symposium Contribution of Tau studies to Neuroregenerative Medicine & Development of Biomedical Engineering Tools March 6 th, 2018 8.45 am 14.00 pm Da An Campus, Room B204
More informationThe University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Catalog Addendum
The University of Texas MD Anderson Cancer Center UTHealth 2016-2018 Catalog Addendum GSBS 2016-18 Catalog Addendum Table of Contents School Name Change... 1 Areas of Research Concentration Changes...
More informationGenomic Medicine for the University of Vermont Health Network
Genomic Medicine for the University of Vermont Health Network The heart and science of medicine. Debra G.B. Leonard, M.D., Ph.D. Chair & Professor, Pathology & Laboratory Medicine Robert Larner, M.D. College
More informationGenomics Changing the Way Care is Delivered
Genomics Changing the Way Care is Delivered Eric P. Hoffman, PhD Director, Center for Genetic Medicine Research A. James Clark Professor of Molecular Genetics Children s National Medical Center Washington,
More informationORPHANET s Services for Researchers. Valérie THIBAUDEAU Database Manager Orphanet
ORPHANET s Services for Researchers Valérie THIBAUDEAU Database Manager Orphanet Services for Researchers Needs Access classifications, genes Identify experts Collaborate Quickly recruit volunteers Establish
More informationPrecision Medicine in Sepsis
Precision Medicine in Sepsis Jean-Daniel Chiche, MD PhD jean-daniel.chiche@aphp.fr MICU & Dept Infection, Immunity & Inflammation Hôpital Cochin & Institut Cochin, Paris-F Sepsis 2017: a litany of failed
More informationDiscovery of drugs and drug resistance. Model organisms. Plants and livestock. Cell-based disease modelling. Therapeutics
Genome editing for the engineering of cell lines and animal models Major applications are in: Discovery of drugs and drug resistance Model organisms Plants and livestock Cell-based disease modelling Therapeutics
More informationTowards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory
Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory Bull, 2012 Natalia Jiménez Lozano Business Development Manager BULL e-health Consultancy & Business Solutions Tlf: 913939253
More informationStem cells for therapeutic use
Transition to an industrial scale of human stem cell production for therapeutic use by Bruno JARRY, Jean-François STOLTZ and Raymond ARDAILLOU on behalf of a working group joining Academy of Technologies
More informationDNA Studies (Genetic Studies) Disclosure Statement. Definition of Genomics. Outline. Immediate Present and Near Future
Advances in Genetic Marker Evaluation Prior to Vascular Access Creation Timmy Lee, M.D., M.S.P.H., F.A.C.P., F.A.S.N. Assistant Professor of Medicine Division of Nephrology and Hypertension University
More informationKnowing changes everything.
SYRACUSE, NEW YORK CLINICAL UPDATE May 2009 $6.2 million for Stem Cell Research SUNY Upstate s well-established stem cell research program receives a massive boost from NYSTEM. GPS for Prostate University
More informationOverview: Towards a European open source knowledge management infrastructure. Scott Wagers, MD BioSci Consulting
Overview: Towards a European open source knowledge management infrastructure Scott Wagers, MD BioSci Consulting Innovative Medicines Initiative: Joining Forces in the Healthcare Sector U-BIOPRED Annual
More informationLes Biomarqueurs: une composante essentielle de la Recherche Translationnelle
Les Biomarqueurs: une composante essentielle de la Recherche Translationnelle Jesús Benavides Ancien Directeur de la Recherche Maladies Neurologiques. Sanofi Ecole Doctorale Biosigne. Université Paris
More informationInnovative Medicines Initiative Sadallah Fatiha IMI JU Office, Brussels, Belgium
Innovative Medicines Initiative 2 2009-2014 Sadallah Fatiha IMI JU Office, Brussels, Belgium The Evolution of IMI: From bottlenecks in industry to bottlenecks in Industry and Society Make Drug R&D processes
More informationSSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview
SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy
More informationUpdating International Ethics Guidelines for Stem Cell Research
Updating International Ethics Guidelines for Stem Cell Research Jeremy Sugarman, MD, MPH, MA Harvey M. Meyerhoff Professor of Bioethics & Medicine Department of Medicine Berman Institute of Bioethics Johns
More informationA new strategy for genetics & pharmacogenomics (GpGx) Robert M. Plenge, MD, PhD Vice President Head of Genetics & Pharmacogenomics
A new strategy for genetics & pharmacogenomics (GpGx) Robert M. Plenge, MD, PhD Vice President Head of Genetics & Pharmacogenomics 1 Robert Plenge Our Shared Goals Impact the entire pipeline Drive early
More informationPer Morten Sandset Japan-UiO cooperation within health and care research status and opportunities
Per Morten Sandset p.m.sandset@medisin.uio.no Japan-UiO cooperation within health and care research status and opportunities Japan-UiO cooperation within health and care Brief presentation of the University
More informationCan High Performance Computing Help Cure Pharma R&D?
Can High Performance Computing Help Cure Pharma R&D? Philippe Guillet, MD Unité Vieillissement Sanofi R&D Teratec Forum 2013 26/06/13 TERATEC Forum 2013 Ecole Polytechnique Palaiseau June 25-26 2013 Trends
More informationATIP Avenir Program 2018 Young group leader
ATIP Avenir Program 2018 Young group leader Important dates - October 17th (4 pm) 2017 : opening of the registrations online - November 23 th 2017: deadline for the online submission, the mailing of the
More informationE&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015
E&T objectives in evolving pharma business models Magda Chlebus Director Science Policy Brussels, 2 March 2015 Education adapted to demand? Declining number of students choosing science Education still
More informationOverview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017
FNR Overview of the Luxembourg biomedical and health research ecosystem FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 Research in Luxembourg Luxembourg : a young research location Creating structures
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationImplementing Biomedical Informatics Approaches to Facilitate Translational and Clinical Research
Implementing Biomedical Informatics Approaches to Facilitate Translational and Clinical Research Institute of Medicine May 30, 2014 David A. Fenstermacher, Ph.D. Chief Research Information Officer Professor,
More informationReport on research unit:
Department of Research evaluation Report on research unit: Plasticity of Airway Epithelium in Normal and Pathological Conditions P3Cell Under the supervision of the following institutions and research
More informationPS02 Biomarker Analysis. Discussant. Sue-Jane Wang, Ph.D.
PS02 Biomarker Analysis Discussant Sue-Jane Wang, Ph.D. Associate Director, Adaptive Design, Pharmacogenomics/Phrmacogenetics Office of Biostatistics, Office of Translational Sciences, CDER CDER Statistics
More informationExtramural Research Pulmonary Arterial Hypertension. James P. Kiley, M.S., Ph.D. June 20, 2008
Extramural Research Pulmonary Arterial Hypertension James P. Kiley, M.S., Ph.D. June 20, 2008 Outline Overview DLD Programs in PH NHLBI Strategic Plan Future Directions What s new at NIH Current Extramural
More informationLeveraging an Academic-Industry Partnership for Commercial Success
Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,
More informationNIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts)
NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts) 1. NCI (National Cancer Institute) cancer cause, prevention, detection, diagnosis, treatment and control 2. NIAID
More informationOur website:
Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate
More informationNINDS/HEAL Biomarker Programs New Biomarker Initiatives at NIH: Neurological Disorders and Pain
NINDS/HEAL Biomarker Programs New Biomarker Initiatives at NIH: Neurological Disorders and Pain OCTOBER 30, 2018 Mary Ann Pelleymounter, PhD Program Director mary.pelleymounter@nih.gov 1 About the Speaker
More informationHorizon 2020 Review of Work Programme Focus on topics including Clinical Trials/Studies
Horizon 2020 Review of Work Programme 2018 2020 Focus on topics including Clinical Trials/Studies ECRIN European Correspondent Meeting Dr Sabine Klager - 08/11/2017 Health, demographic change and wellbeing
More informationCompanion Diagnostics in Autoimmune Disorders: Improving Outcomes Through Personalized Medicine
Companion Diagnostics in Autoimmune Disorders: Improving Outcomes Through Personalized Medicine Carrie Brodmerkel, PhD Immunology Biomarkers Janssen R&D 1 Immune-Mediated Diseases Rheumatoid Arthritis
More informationATIP Avenir Program 2018 Young group leader. Guide for applicants
ATIP Avenir Program 2018 Young group leader Guide for applicants Important dates - November 23 rd 2017: deadline for the online submission, the mailing of the hard copy of the scientific project, and the
More information- OMICS IN PERSONALISED MEDICINE
SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary
More informationNordic Common Strengths and Future Potential in the Field of Personalised Medicine
Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research
More informationBSc BIOMEDICAL SCIENCE
Overview College of Science Biomedical Science Core March 2017 (1) BSc BIOMEDICAL SCIENCE Biomedical Science Degree 2015 1 College of Science, NUI Galway Fullscreen Next page Overview [60 credits] [60
More informationDévelopper de nouvelles variétés de blé pour une agriculture durable : une approche intégrée de la génomique à la sélection
Développer de nouvelles variétés de blé pour une agriculture durable : une approche intégrée de la génomique à la sélection Breeding for economically and environmentally sustainable wheat varieties: an
More informationClinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE
Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.
More informationDepartment of Research Evaluation. Theory and Approaches of Genomics Complexity TAGC
Department of Research Evaluation report on the research unit: Theory and Approaches of Genomics Complexity TAGC under the supervision of the following institutions and research bodies: Aix-Marseille Université
More informationRegulatory Perspectives on Gene Therapies for Rare Diseases Rare Diseases Forum Washington, D.C. October 17, 2018
Regulatory Perspectives on Gene Therapies for Rare Diseases Rare Diseases Forum Washington, D.C. October 17, 2018 Rachel Witten, M.D. Medical Officer Office of Tissues and Advanced Therapies Center for
More informationNew Frontiers in Personalized Medicine
New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended
More informationIntroducing the Department of Life Sciences
Introducing the Department of Life Sciences Life Sciences is a discipline that aims at a fundamental understanding of life phenomena by exploring complex and mysterious structures and funct ions of living
More informationProjet EuCP European Certified Pharmacologists. Utrecht mars
Projet EuCP European Certified Pharmacologists Utrecht 27-28 mars Background «In many countries world-wide, pharmacologists have raised concerns that pharmacology as a discipline is under threats of disappearing.
More informationDrug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research
Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities
More informationPredictive Genomics for Prevention, Interception and Cure Health Datapalooza
Predictive Genomics for Prevention, Interception and Cure Health Datapalooza Emma Huang Population Analytics 27 April 2017 1 Looking to the future, our goal is to leverage the unprecedented advances in
More informationWe would like to acknowledge and thank the following supporters of this workshop:
We would like to acknowledge and thank the following supporters of this workshop: University of Pittsburgh o Clinical and Translational Science Institute o Drug Discovery Institute o Institute for Personalized
More informationNIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of
NIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of Health AIRI Meeting October 2, 2017 Topics Budget Update
More informationThe Role of the NIH Clinical Center in Translational and Clinical Research
The Role of the NIH Clinical Center in Translational and Clinical Research International Conference on Engineering Science and Technology 2014 John I. Gallin, M.D. Director, NIH Clinical Center Associate
More informationA whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger
A whole-system approach to delivering personalised medicine and health in Leeds Mike Messenger Capacity and Resource What is the challenge? In 2016, we face the most significant challenges for a generation.
More informationThe Changing Paradigm of Tropical Medicine: The Role of TropMed Mahidol
Discussion on To be a World Leader in Tropical Medicine Faculty of Tropical Medicine, Mahidol University, 29 May 2015 The Changing Paradigm of Tropical Medicine: The Role of TropMed Mahidol Yongyuth Yuthavong
More information4 th ESPT SUMMER SCHOOL
4 th ESPT SUMMER SCHOOL PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you to the 4th ESPT
More informationBIOTECH IN FRANCE. key info in. points
BIOTECH IN FRANCE 10 key info in points 1 2 3 INSERM: EUROPE S #1 ACADEMIC BIOTECH RESEARCH INSTITUTE INSERM spearheads healthcare and medical research in France, filing more biotech patents with the European
More informationNew test for transplant rejection on the horizon
December 6, 2004 New test for transplant rejection on the horizon Vancouver Researchers at St. Paul s Hospital and Vancouver General Hospital are developing a revolutionary new test to diagnose and facilitate
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationGenetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health
Genetics/Genomics in Public Health Role of Clinical and Biochemical Geneticists in Public Health Premises Human variation is vast Strength of genetic factors are a continuum from low to high Testing technology
More informationAntibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
More information1.0 Background to the organisation
1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their
More informationUniversity of Eastern Finland (UEF) Main Research Lines
University of Eastern Finland (UEF) Main Research Lines Asla Pitkänen, MD, PhD Epilepsy Research Laboratory A.I.Virtanen Institute for Molecular Sciences University of Eastern Finland Kuopio, Finland E-mail:
More informationATIP Avenir Program 2019 Young group leader. Guide for applicants
ATIP Avenir Program 2019 Young group leader Guide for applicants Important dates - November 15 th 2018: deadline for the online submission, and the letters of recommendation - Mid-April 2019: publication
More informationDepartment of Research Evaluation. Université de Poitiers Institut National de la Santé Et de la Recherche Médicale - INSERM
Department of Research Evaluation Report on research unit: Pharmacology of Antimicrobial Agents PHAR under the supervision of the following institutions and research bodies: Université de Poitiers Institut
More informationEleventh Annual Chapel Hill Pharmaceutical Sciences Conference. Pharmacy in the Era of Precision Medicine: From Discovery to Implementation
Eleventh Annual Chapel Hill Pharmaceutical Sciences Conference Pharmacy in the Era of Precision Medicine: From Discovery to Implementation May 18 19, 2017 The Carolina Inn, Chapel Hill, NC Co-Chairs: Daniel
More informationMultiple Myeloma Training for Physicians 2018
Multiple Myeloma Training for Physicians 2018 Objective and Aim: The National University Cancer Institute, Singapore (NCIS) is the only public cancer centre in Singapore treating both paediatric and adult
More informationAdvancing Manufacturing for Advanced Therapies
Advancing Manufacturing for Advanced Therapies Peter Marks, MD, PhD Center For Biologics Evaluation and Research, FDA CASSS Cell & Gene Therapy Symposium July 10, 2018 Overview Cell and gene therapy products
More informationOverview. FTD Genetics where is it leading us? What comes first or? Family History. AFTD Education Conference and Annual Meeting, White Plains, 2014
Genetics where is it leading us? Jill Goldman, MS, MPhil, CGC Taub Institute Columbia University Medical Center Overview Why are there so many research studies on the genetics of? How much of is genetic?
More informationHealthy Ageing. From Basic Science to Clinical Applications and New Business. Jan Sikkema Center for Development and Innovation June 16, 2016
Healthy Ageing From Basic Science to Clinical Applications and New Business Jan Sikkema Center for Development and Innovation June 16, 2016 Groningen Broad Research University 11 faculties > 30.000 students
More informationOverview of NIBIB Research Areas and Funding Opportunities. There are 27 Institutes and Centers (ICs) at the NIH NIBIB
Overview of NIBIB Research Areas and Funding Opportunities National Institute of Biomedical Imaging and Bioengineering AAPM August 2, 2016 Steven Krosnick, MD krosnics@mail.nih.gov There are 27 Institutes
More informationTARGET VALIDATION. Maaike Everts, PhD (with slides from Dr. Suto)
TARGET VALIDATION Maaike Everts, PhD (with slides from Dr. Suto) Drug Discovery & Development Source: http://dlab.cl/molecular-design/drug-discovery-phases/ How do you identify a target? Target: the naturally
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationNIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE
NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE EXPERTISE AND CAPABILITIES The TRC in Inflammatory Respiratory Disease provides cutting-edge expertise in the development of exploratory
More informationUS Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office
US Food and Drug Administration Sandra L. Kweder, MD Deputy Director, Europe Office Basics Disclaimer The views in this presentation are my own I have no commercial involvement in any of these activities
More informationHCERES report on research unit: Under the supervision of the following institutions and research bodies: Oxidative Stress and Metabolic Diseases SOPAM
Research units HCERES report on research unit: Oxidative Stress and Metabolic Diseases SOPAM Under the supervision of the following institutions and research bodies: Université d Angers - UA Institut National
More informationWhat IMI means for POLAND
What IMI means for POLAND Maciej Bagiński Gdansk University of Technology Deputy of Polish Delegate to IMI SRG History of calls 1 st call 15 projects (395 teams) 281 mln 2 nd call 8 projects (193 teams)
More informationThe National Institutes of Health ICs: mission and funding strategies
The National Institutes of Health ICs: mission and funding strategies Perry Kirkham, Ph.D. Office of the Vice President for Research E-mail: pkirkham@purdue.edu Phone: 63645 NIH Workshop topics and dates
More information